Disregarded for decades, extracellular vesicles are now understood to be a key element in communication...
Up To Date
Backgrounds & Stories
For over three decades, attempts among drug developers to target the inflammatory pathways and symptoms of...
Although most people still view carbon dioxide (CO2) as a climate killer, industry is beginning to realise...
The European Medicines Agency’s new, accelerated route to approval for innovative drugs seems to be especially...
The US has opened the floodgates to cheaper versions of biologic medicines, and analysts predict that by 2020,...
Amgen’s Imlygic was approved last year – a move that finally added oncolytic viruses (OVs) to the healthcare...